Literature DB >> 23044021

Ventriculoperitoneal shunt strategy for cerebrospinal fluid rhinorrhea repair: a case report and review of the literature.

Jihong Tang1, Yuxia Zhu, Bingbing Zhang, Qing Gu, Yang Li.   

Abstract

We present a 10-year-old boy with a greater than 5-year history of cerebrospinal fluid rhinorrhea. He experienced nine episodes of bacterial meningitis and underwent four surgical repairs, including two endoscopic repairs via the lateral nasal cavity, a craniotomy repair via forehead epidural, and endoscopic repair in combination with a ventriculoperitoneal shunt. The first three surgeries failed, but the fourth was successful, with no recurrence during 2.5 years of follow-up. We suggest that ventriculoperitoneal shunts be considered for refractory recurrent cerebrospinal fluid rhinorrhea, particularly in patients after multiple failures of conventional surgical repair, to reduce intracranial hypertension caused by long-term chronic cerebrospinal fluid compensatory production.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23044021     DOI: 10.1016/j.pediatrneurol.2012.07.010

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  CSF Rhinorrhea Following Medical Treatment for Prolactinoma: Management and Challenges.

Authors:  Arivazhagan Arimappamagan; Nishanth Sadashiva; Sandeep Kandregula; Dhaval Shukla; Sampath Somanna
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-21

2.  Cerebrospinal fluid rhinorrhea in a bilateral frontal decompressive craniectomy patient caused by strenuous activity: A case report.

Authors:  Guangming Wang; Lichao Sun; Wenchen Li; Jinlu Yu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

3.  Ventriculoperitoneal Shunt Alone for Cerebrospinal Fluid Rhinorrhea With Neuroendocrine Alterations in Idiopathic Intracranial Hypertension: A Case Report and Literature Review.

Authors:  Deqing Peng; Kaichuang Yang; Cheng Wu; Faliang Gao; Weijun Sun; Gang Lu
Journal:  Front Neurol       Date:  2022-02-10       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.